The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 11, 2023

Filed:

Jul. 08, 2016
Applicants:

Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;

Université Claude Bernard Lyon 1, Villeurbanne, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Ecole Normale Superieure DE Lyon, Lyons, FR;

Inventors:

Floriane Fusil, Lyons, FR;

Els Verhoeyen, Nice, FR;

Thierry Defrance, Lyons, FR;

François-Loïc Cosset, Lyons, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/46 (2006.01); C12N 15/62 (2006.01); C12N 15/86 (2006.01); A61K 48/00 (2006.01); C07K 16/10 (2006.01); A61K 39/29 (2006.01); A61P 37/02 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); C12N 15/113 (2010.01); C12N 15/85 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/109 (2013.01); A61K 39/29 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); A61P 37/02 (2018.01); C07K 16/00 (2013.01); C12N 15/113 (2013.01); C12N 15/62 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5256 (2013.01); C07K 2317/10 (2013.01); C07K 2317/76 (2013.01); C07K 2319/03 (2013.01); C12N 2740/15043 (2013.01); C12N 2810/6054 (2013.01); C12N 2830/008 (2013.01); C12N 2830/20 (2013.01); C12N 2830/42 (2013.01); C12N 2830/48 (2013.01); C12N 2830/50 (2013.01);
Abstract

The invention concerns a multicistronic nucleic acid, in particular an isolated multicistronic nucleic acid, comprising: A) a sequence comprising successively: A1) a sequence encoding the light chain variable domain of an antibody of interest, fused in the frame with A2) a sequence encoding the constant region of the light chain of an immunoglobulin Ig; and B) a sequence comprising successively: B1) a sequence encoding the heavy chain variable domain of said antibody of interest, fused in the frame with B2) a sequence encoding the constant regions of the heavy chain of an immunoglobulin Ig' in secretory form; B3) an intronic sequence of the gene of the heavy chain of said immunoglobulin Ig′, said intronic sequence comprising an internal 5′ splice site enabling the splicing of said intronic sequence B3) and a secretory-specific poly(A) (p AS) signal from the 3′ terminal exon of said gene; B4) a sequence, in frame with sequence B1), encoding the transmembrane and cytoplasmic domains M1 and M2 of the immunoglobulin Ig′ BCR, wherein said sequence B4) comprises, between the coding sequences of the M1 and M2 domains, an intronic sequence containing a splice site enabling the splicing of said intronic sequence between the M1 and M2 domains coding sequences; and B5) a membrane-anchored specific poly(A) signal (p AM), after the stop codon of the M2 domain, wherein the multicistronic nucleic acid enables the co-expression of the sequences A and B into separate proteins.


Find Patent Forward Citations

Loading…